Teva recalls lot of metronidazole tablets

Jan 09, 2011
By staff
Washington — Teva Pharmaceuticals recalled one lot of metronidazole tablets, according to the U.S. Food and Drug Administration (FDA). FDA says the recall was initiated because the tablets may not contain the full amount of active ingredient, which could could result in treatment failure. Metronidazole is used to treat a variety of anaerobic bacterial infections, asymptomatic trichomoniasis, amebiasis and other conditions.

The recall affects Teva’s metronidazole tablets usp, 250 mg, lot number 312566 with an expiration date of May 2012. The tablets were distributed nationwide to wholesalers and retailers in 250-count bottles.

Recalled products can be returned to the place of purchase, FDA adds.